Cannabis Stock Gainers And Losers From July 31, 2024
Marijuana Stock Movers For October 11, 2023
Marijuana Stock Movers For October 2, 2023
Empower Clinics Announces Closing of Second Tranche Private Placement Financing
Empower Clinics Announces Closing of First Tranche Private Placement Financing
Empower Clinics Announces Proposal For Division Spin Out
Empower Clinics Signs New Agreements To Advance Growth Of Research and Clinical Trials With Signing Of Two Additional Principal Investigators - And Are Approved To Process Multiple Clinical Study Applications From Pharmaceutical Sponsors
CSE Bulletin: Consolidation - Empower Clinics Inc. (EPW)
EMPOWER CLINICS INC To Carry Out 1-for-5 Reverse Stock Split On June 21st, 2023
June 20th - $EMPOWER CLINICS INC(EPWCF.US)$ is about to implement a 1-for-5 reverse stock split of shares. The shares will begin trading on a split-adjusted basis from June 21st, 2023.$EMPOWER CLINICS
Empower Clinics Announces Share Consolidation
Empower Clinics Signs LOI for C$5M Equity Capital Facility
Empower Clinics Signs Letter of Intent for $5 Million Equity Capital Facility and Provides Additional Corporate Updates
Empower Clinics Provides Corporate Update
Empower Clinics Advances Research and Clinical Trials Division With The Signing of Another Experienced Principal Investigator
Empower Clinics Accelerates Growth of Research and Clinical Trials Division With Signing of Two Additional Principal Investigators at First Site in Dallas, Texas
Empower Clinics Announces Official Launch of Mobile Technology & Communications Platform, PulseIR Powered by Fobi
Empower Clinics Signs Agreement To Conduct Research and Clinical Trials With Dallas, TX Based Medical Center - And Major Milestone With Signing Of Research Services Agreement With First Principal Investigator
Empower Clinics Announces Exploration of Strategic Alternatives
Empower Clinics Cancels Previously Announced Private Placement
Empower Clinics Advances Partnership to Launch US Clinical Trial Management Services With Formation of Delaware Based Company and Identification of Principal Investigators